← Back to the feed

New York Times Op-Docs Acquires ‘The Revolution Against Death,’ Oscar Nominee Joshua Oppenheimer’s Film On Quest For Immortality

Deadline ·

The New York Times’ Op-Docs has acquired *The Revolution Against Death*, a short documentary by two-time Oscar nominee Joshua Oppenheimer. The film will be co-released worldwide with MUBI in early December, bringing Oppenheimer’s personal exploration of the pursuit of immortality to a wider audience.

Set at an annual longevity conference called the Revolution Against Aging and Death Festival, the film examines fears around illness, ageing and dying, as well as the desire to overcome death. It premiered at Tampere Film Festival and screened at Telluride; upcoming screenings include the Chicago International Film Festival and IDFA in Amsterdam. It is one of eight films on Op-Docs’ 2026 awards-contender slate, and the series has received seven Oscar nominations.

  • Op-Docs acquired Oppenheimer’s short film about the quest for immortality.
  • The film is set at an annual longevity conference.
  • It will be released globally with MUBI in early December.

New here? Start with this

Longevity refers to living for a long time, and some researchers and technology advocates are exploring ways to slow ageing or extend human life. Their work draws attention as people consider how longer lives might affect health, society and the limits of medical science.

The film is set at a festival where people discuss efforts to overcome ageing and death. It follows director Joshua Oppenheimer’s personal exploration of the hopes and fears behind that pursuit, including concerns about illness and dying. The New York Times’ Op-Docs is its short documentary series, and MUBI is a film streaming service.

Americas World

Read the full article at the source →

Cookie-free view counts · Privacy choices

We count page views to improve this website, including before you choose optional analytics. This counter keeps only a daily total: no visitor IDs, page addresses or browsing histories. It uses no tracking cookies and sends no data to Google or Microsoft. Optional analytics add richer reports if you accept them.

Your choice is remembered using a preference cookie. Rejecting analytics, Do Not Track and Global Privacy Control also stop this counter. Ordinary server access logs are separate.